189 related articles for article (PubMed ID: 6749275)
1. Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy.
Hays DM; Raney RB; Lawrence W; Soule EH; Gehan EA; Tefft M
Cancer; 1982 Oct; 50(8):1472-82. PubMed ID: 6749275
[TBL] [Abstract][Full Text] [Related]
2. Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II).
Hays DM; Raney RB; Lawrence W; Tefft M; Soule EH; Crist WM; Foulkes M; Maurer HM
J Pediatr Surg; 1982 Dec; 17(6):812-20. PubMed ID: 6761418
[TBL] [Abstract][Full Text] [Related]
3. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
Hays DM; Raney RB; Wharam MD; Wiener E; Lobe TE; Andrassy RJ; Lawrence W; Johnston J; Webber B; Maurer HM
J Pediatr Hematol Oncol; 1995 Feb; 17(1):46-52. PubMed ID: 7743237
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.
Raney RB; Gehan EA; Maurer HM; Newton WA; Ragab AH; Ruymann FB; Sutow WW; Tefft M
Cancer Clin Trials; 1979; 2(1):19-28. PubMed ID: 391431
[TBL] [Abstract][Full Text] [Related]
5. Partial cystectomy in the management of rhabdomyosarcoma of the bladder: a report from the Intergroup Rhabdomyosarcoma Study.
Hays DM; Lawrence W; Crist WM; Wiener E; Raney RB; Ragab A; Tefft M; Webber B; Johnston J; Maurer HM
J Pediatr Surg; 1990 Jul; 25(7):719-23. PubMed ID: 2380887
[TBL] [Abstract][Full Text] [Related]
6. The Intergroup Rhabdomyosarcoma Study-II.
Maurer HM; Gehan EA; Beltangady M; Crist W; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J
Cancer; 1993 Mar; 71(5):1904-22. PubMed ID: 8448756
[TBL] [Abstract][Full Text] [Related]
7. The Intergroup Rhabdomyosarcoma Study-I. A final report.
Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J
Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486
[TBL] [Abstract][Full Text] [Related]
8. The Third Intergroup Rhabdomyosarcoma Study.
Crist W; Gehan EA; Ragab AH; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J; Heyn R
J Clin Oncol; 1995 Mar; 13(3):610-30. PubMed ID: 7884423
[TBL] [Abstract][Full Text] [Related]
9. Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II.
Raney RB; Gehan EA; Hays DM; Tefft M; Newton WA; Haeberlen V; Maurer HM
Cancer; 1990 Nov; 66(10):2072-81. PubMed ID: 2224761
[TBL] [Abstract][Full Text] [Related]
10. Rhabdomyosarcoma of the bladder and prostate in children.
Kamat MR; Kulkarni JN; Tongaonkar HB; Ravi R
J Surg Oncol; 1991 Nov; 48(3):180-2. PubMed ID: 1943114
[TBL] [Abstract][Full Text] [Related]
11. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
12. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
[TBL] [Abstract][Full Text] [Related]
13. The Intergroup Rhabdomyosarcoma Study: update, november 1978.
Maurer HM
Natl Cancer Inst Monogr; 1981 Apr; (56):61-8. PubMed ID: 7029297
[TBL] [Abstract][Full Text] [Related]
14. The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma.
Lobe TE; Wiener E; Andrassy RJ; Bagwell CE; Hays D; Crist WM; Webber B; Breneman JC; Reed MM; Tefft MC; Heyn R
J Pediatr Surg; 1996 Aug; 31(8):1084-7. PubMed ID: 8863239
[TBL] [Abstract][Full Text] [Related]
15. [Rhabdomyosarcoma: therapeutic results and prospectives].
Guglielmi M; Carli M
Pediatr Med Chir; 1984; 6(2):179-84. PubMed ID: 6549408
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of bladder and prostatic neoplasms in children].
Bozek J; Czerwiński W; Jurczyk-Procyk S; Taube K
Probl Med Wieku Rozwoj; 1979; 9():324-8. PubMed ID: 400771
[TBL] [Abstract][Full Text] [Related]
17. Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study.
Hays DM
Semin Surg Oncol; 1993; 9(6):520-3. PubMed ID: 8284571
[TBL] [Abstract][Full Text] [Related]
18. [Rhabdomyosarcoma of the bladder: a case report].
Kobayashi H; Kido K; Koie T; Ohyanagi H
Gan To Kagaku Ryoho; 1996 Feb; 23(3):365-8. PubMed ID: 8712832
[TBL] [Abstract][Full Text] [Related]
19. A therapeutic approach to childhood pelvic rhabdomyosarcoma without pelvic exenteration.
Ortega JA
J Pediatr; 1979 Feb; 94(2):205-9. PubMed ID: 762607
[TBL] [Abstract][Full Text] [Related]
20. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
Ortega JA; Donaldson SS; Ivy SP; Pappo A; Maurer HM
Cancer; 1997 Jun; 79(12):2435-9. PubMed ID: 9191535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
